These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 37232876)
1. Fluorescent Sensing Platforms for Detecting and Imaging the Biomarkers of Alzheimer's Disease. Liu X; Liu Y; Liu Q Biosensors (Basel); 2023 Apr; 13(5):. PubMed ID: 37232876 [TBL] [Abstract][Full Text] [Related]
2. Current trends in blood biomarker detection and imaging for Alzheimer's disease. Hu S; Yang C; Luo H Biosens Bioelectron; 2022 Aug; 210():114278. PubMed ID: 35460969 [TBL] [Abstract][Full Text] [Related]
4. Alzheimer's cerebrospinal biomarkers from Lumipulse fully automated immunoassay: concordance with amyloid-beta PET and manual immunoassay in Koreans : CSF AD biomarkers measured by Lumipulse in Koreans. Moon S; Kim S; Mankhong S; Choi SH; Vandijck M; Kostanjevecki V; Jeong JH; Yoon SJ; Park KW; Kim EJ; Yoon B; Kim HJ; Jang JW; Hong JY; Park DH; Shaw LM; Kang JH Alzheimers Res Ther; 2021 Jan; 13(1):22. PubMed ID: 33436035 [TBL] [Abstract][Full Text] [Related]
5. [Potential biomarkers of early diagnosis of Alzheimer's disease]. Bogolepova AN; Makhnovich EV; Kovalenko EA; Osinovskaya NA Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(9):7-14. PubMed ID: 36168682 [TBL] [Abstract][Full Text] [Related]
6. Critical Comparison of Different Biomarkers for Alzheimer's Disease in a Clinical Setting. Weise D; Tiepolt S; Awissus C; Hoffmann KT; Lobsien D; Kaiser T; Barthel H; Sabri O; Gertz HJ J Alzheimers Dis; 2015; 48(2):425-32. PubMed ID: 26402006 [TBL] [Abstract][Full Text] [Related]
8. Testing the 2018 NIA-AA research framework in a retrospective large cohort of patients with cognitive impairment: from biological biomarkers to clinical syndromes. Carandini T; Arighi A; Sacchi L; Fumagalli GG; Pietroboni AM; Ghezzi L; Colombi A; Scarioni M; Fenoglio C; De Riz MA; Marotta G; Scarpini E; Galimberti D Alzheimers Res Ther; 2019 Oct; 11(1):84. PubMed ID: 31615545 [TBL] [Abstract][Full Text] [Related]
9. Oligomeric forms of amyloid-β protein in plasma as a potential blood-based biomarker for Alzheimer's disease. Wang MJ; Yi S; Han JY; Park SY; Jang JW; Chun IK; Kim SE; Lee BS; Kim GJ; Yu JS; Lim K; Kang SM; Park YH; Youn YC; An SSA; Kim S Alzheimers Res Ther; 2017 Dec; 9(1):98. PubMed ID: 29246249 [TBL] [Abstract][Full Text] [Related]
10. Blood-based high sensitivity measurements of beta-amyloid and phosphorylated tau as biomarkers of Alzheimer's disease: a focused review on recent advances. Chong JR; Ashton NJ; Karikari TK; Tanaka T; Schöll M; Zetterberg H; Blennow K; Chen CP; Lai MKP J Neurol Neurosurg Psychiatry; 2021 Nov; 92(11):1231-1241. PubMed ID: 34510001 [TBL] [Abstract][Full Text] [Related]
11. Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative. Veitch DP; Weiner MW; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Morris JC; Petersen RC; Saykin AJ; Shaw LM; Toga AW; Trojanowski JQ; Alzheimers Dement; 2019 Jan; 15(1):106-152. PubMed ID: 30321505 [TBL] [Abstract][Full Text] [Related]
12. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model. Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W; J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262 [TBL] [Abstract][Full Text] [Related]
13. Predictive Accuracy of Blood-Derived Biomarkers for Amyloid-β Brain Deposition Along with the Alzheimer's Disease Continuum: A Systematic Review. Cianflone A; Coppola L; Mirabelli P; Salvatore M J Alzheimers Dis; 2021; 84(1):393-407. PubMed ID: 34542072 [TBL] [Abstract][Full Text] [Related]
14. Correlation of Alzheimer Disease Neuropathologic Staging with Amyloid and Tau Scintigraphic Imaging Biomarkers. Koychev I; Hofer M; Friedman N J Nucl Med; 2020 Oct; 61(10):1413-1418. PubMed ID: 32764121 [TBL] [Abstract][Full Text] [Related]
15. Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease. Mattsson N; Insel PS; Donohue M; Landau S; Jagust WJ; Shaw LM; Trojanowski JQ; Zetterberg H; Blennow K; Weiner MW; Brain; 2015 Mar; 138(Pt 3):772-83. PubMed ID: 25541191 [TBL] [Abstract][Full Text] [Related]
16. Chemical sensing platforms for detecting trace-level Alzheimer's core biomarkers. Kim K; Lee CH; Park CB Chem Soc Rev; 2020 Aug; 49(15):5446-5472. PubMed ID: 32627779 [TBL] [Abstract][Full Text] [Related]
17. Fluid and PET biomarkers for amyloid pathology in Alzheimer's disease. Cohen AD; Landau SM; Snitz BE; Klunk WE; Blennow K; Zetterberg H Mol Cell Neurosci; 2019 Jun; 97():3-17. PubMed ID: 30537535 [TBL] [Abstract][Full Text] [Related]
18. Beta-amyloid sequelae in the eye: a critical review on its diagnostic significance and clinical relevance in Alzheimer's disease. Shah TM; Gupta SM; Chatterjee P; Campbell M; Martins RN Mol Psychiatry; 2017 Mar; 22(3):353-363. PubMed ID: 28093567 [TBL] [Abstract][Full Text] [Related]
19. Comparison of Two Analytical Platforms in Cerebrospinal Fluid Biomarkers for the Classification of Alzheimer's Disease Spectrum with Amyloid PET Imaging. Lim HJ; Park JE; Kim BC; Choi SM; Song MK; Cho SH; Seo HJ; Kim J; Song HC; Choi KY; Lee JJ; Kim HW; Ha JM; Song WK; Park SG; Lee JS; Lee KH J Alzheimers Dis; 2020; 75(3):949-958. PubMed ID: 32390627 [TBL] [Abstract][Full Text] [Related]
20. Biomarker-Based Prediction of Longitudinal Tau Positron Emission Tomography in Alzheimer Disease. Leuzy A; Smith R; Cullen NC; Strandberg O; Vogel JW; Binette AP; Borroni E; Janelidze S; Ohlsson T; Jögi J; Ossenkoppele R; Palmqvist S; Mattsson-Carlgren N; Klein G; Stomrud E; Hansson O JAMA Neurol; 2022 Feb; 79(2):149-158. PubMed ID: 34928318 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]